Status:

RECRUITING

Antibiotic Prophylaxis for Bladder Botox

Lead Sponsor:

University of Alberta

Collaborating Sponsors:

Women and Children's Health Research Institute, Canada

Conditions:

Idiopathic Overactive Bladder

Postoperative Urinary Tract Infection

Eligibility:

FEMALE

18+ years

Phase:

PHASE4

Brief Summary

Injection of Botox into the bladder is a common treatment for overactive bladder. Postoperative bladder infection is one of the more frequently reported complications of this procedure. Prophylactic a...

Detailed Description

This study will be a single-centred, double-blinded, randomized, placebo-controlled trial. Recruitment will be undertaken at two Urogynecology/Urology sites associated with the University of Alberta i...

Eligibility Criteria

Inclusion

  • Patients with idiopathic OAB diagnosed clinically who have failed medical management
  • Female
  • Age ≥ 18

Exclusion

  • Patients with neurogenic OAB (OAB with potential underlying neurologic cause - multiple sclerosis, spinal cord injury, Parkinson's disease, other)
  • Contraindication to injection of Botox - hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, current urinary tract infection, symptomatic urinary retention or PVR \> 200 mL, unwillingness or inability to initiate CIC post-treatment if required.
  • Contraindication to oral Ciprofloxacin - hypersensitivity or allergy to Ciprofloxacin or other fluoroquinolone, concurrently taking Tizanidine or Agomelatine.14
  • Active antibiotic therapy for any indication at the time of Botox injection - increased risk of adverse reaction with combining antibiotics, reduced risk of UTI with additional antibiotic.
  • Male
  • Age \< 18
  • Pregnant and/or breastfeeding

Key Trial Info

Start Date :

June 28 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2026

Estimated Enrollment :

202 Patients enrolled

Trial Details

Trial ID

NCT04444440

Start Date

June 28 2021

End Date

June 30 2026

Last Update

September 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Urogynecology Clinic - Royal Alexandra Hospital

Edmonton, Alberta, Canada, T5H3V9

Antibiotic Prophylaxis for Bladder Botox | DecenTrialz